A Case Report on Teriparatide Treatment in Non-Uniting Fracture

The goal of this case report is to describe the Indian experience with Teriparatide in 5 cases of delayed unions and non-unions, as well as in the setting of osteoporotic fractures. Fracture healing issues cause the rehabilitation process to be delayed, which has an influence on quality of life. Both society and patients have a financial burden as a result of the accompanying costs. No systemic treatment for fracture healing has been approved to yet. Teriparatide is a synthetic polypeptide hormone made up of the human parathyroid hormone fragments 1–34. A rising amount of research suggests that it can speed up fracture healing and mend non-unions, in addition to its well-known signal of osteoporosis. Our case report’s main finding is that teriparatide is a potential medication not only for treating osteoporosis but also for accelerating fracture repair. Teriparatide therapy hastens healing, allowing patients to return to regular life and work sooner. It also improves medical resource usage, reduces the likelihood of a second operation, the need for a bone graft, and overall chronic morbidity associated with long-term care. Teriparatide therapy has several advantages: it can be prescribed for any type of fracture, including non-surgical fractures; it can be started at any time; and it can be used throughout the healing process. Our findings are in line with previous studies looking at the effects of Teriparatide on delayed and non-unions in humans.

Author(S) Details

Sujoy Kundu
Residency Chamber, Mahendra Bhatcharya Road, Santragachi, Howrah, West Bengal, India.

View Book:- https://stm.bookpi.org/NHMMR-V1/article/view/6184

Back To Top